Successful Dabrafenib Desensitization Protocols in a Patient with Metastatic Melanoma

Dabrafenib and trametinib are two available molecules that have been approved for the treatment of metastatic melanoma with BRAF-V600E or V600K mutations. Their combined therapy has led to long-lasting survival benefits and substantially improved outcomes. Until now, only a few cases of severe hyper...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Roxana Silvia Bumbacea, Selda Ali, Sabina Loredana Corcea, Dan Corneliu Jinga, Luiza Spiru
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2022-04-01
Cyfres:	Medicina
Pynciau:	dabrafenib hypersensitivity dabrafenib desensitization metastatic melanoma personalized treatment
Mynediad Ar-lein:	https://www.mdpi.com/1648-9144/58/4/511
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!